Working… Menu
Trial record 1 of 1 for:    NCT02927184
Previous Study | Return to List | Next Study

Safety and Tolerability of VK2809 in Patients With Primary Hypercholesterolemia and Non-Alcoholic Fatty Liver Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02927184
Recruitment Status : Completed
First Posted : October 6, 2016
Last Update Posted : May 23, 2019
Information provided by (Responsible Party):
Viking Therapeutics, Inc.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : March 26, 2019
Actual Study Completion Date : March 26, 2019